Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.[1][2]
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Humanized (from mouse) |
| Target | RSV |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
  (what is this?) (verify) | |
References
edit- ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
- ^ Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |